These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 33861209)

  • 1. Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.
    Luo L; King AA; Carroll Y; Baumann AA; Brambilla D; Carpenter CR; Colla J; Gibson RW; Gollan S; Hall G; Klesges L; Kutlar A; Lyon M; Melvin CL; Norell S; Mueller M; Potter MB; Richesson R; Richardson LD; Ryan G; Siewny L; Treadwell M; Zun L; Armstrong-Brown J; Cox L; Tanabe P
    JMIR Res Protoc; 2021 Apr; 10(4):e24818. PubMed ID: 33861209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "The project did not come to us with a solution": Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease.
    Baumann AA; Hankins JS; Hsu LL; Gibson RW; Richardson LD; Treadwell M; Glassberg JA; Bourne S; Luo L; Masese RV; Demartino T; Nocek J; Taaffe E; Gollan S; Ruiz OO; Nwosu C; Qashou N; James AS; Tanabe P; King AA
    BMC Health Serv Res; 2023 Nov; 23(1):1245. PubMed ID: 37953236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
    Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
    J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department.
    Siewny L; King A; Melvin CL; Carpenter CR; Hankins JS; Colla JS; Preiss L; Luo L; Cox L; Treadwell M; Davila N; Masese RV; McCuskee S; Gollan SS; Tanabe P
    Blood Adv; 2024 Oct; 8(20):5330-5338. PubMed ID: 38815230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study.
    Hankins JS; Shah N; DiMartino L; Brambilla D; Fernandez ME; Gibson RW; Gordeuk VR; Lottenberg R; Kutlar A; Melvin C; Simon J; Wun T; Treadwell M; Calhoun C; Baumann A; Potter MB; Klesges L; Bosworth H;
    JMIR Res Protoc; 2020 Jul; 9(7):e16319. PubMed ID: 32442144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
    Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
    Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to pain relief: A randomized controlled trial in the emergency department during vaso-occlusive episodes in sickle cell disease.
    Tanabe P; Bosworth HB; Crawford RD; Glassberg J; Miller CN; Paice JA; Silva S
    Eur J Haematol; 2023 May; 110(5):518-526. PubMed ID: 36602417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE).
    Ibemere SO; Dubbs SB; Barnhart HX; Brown JL; Freiermuth CE; Kavanagh P; Paice JA; Strouse JJ; Wilkerson RG; Tanabe P;
    Contemp Clin Trials; 2021 Feb; 101():106252. PubMed ID: 33348066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Emergency Department Provider Experiences With and Perceptions of Weight-Based Versus Individualized Vaso-Occlusive Treatment Protocols in Sickle Cell Disease.
    Knight LMJ; Onsomu EO; Bosworth HB; Crawford RD; DeMartino T; Glassberg J; Paice JA; Miller CN; Richardson L; Tanabe P
    Adv Emerg Nurs J; 2019; 41(1):86-97. PubMed ID: 30702538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and Facilitators to the Implementation of Family-Centered Technology in Complex Care: Feasibility Study.
    Lin JL; Huber B; Amir O; Gehrmann S; Ramirez KS; Ochoa KM; Asch SM; Gajos KZ; Grosz BJ; Sanders LM
    J Med Internet Res; 2022 Aug; 24(8):e30902. PubMed ID: 35998021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of Implementation of a Mobile Digital Personal Health Record to Coordinate Care for Children and Youth With Special Health Care Needs in Primary Care: Protocol for a Mixed Methods Study.
    Ming DY; Wong W; Jones KA; Antonelli RC; Gujral N; Gonzales S; Rogers U; Ratliff W; Shah N; King HA
    JMIR Res Protoc; 2023 Sep; 12():e46847. PubMed ID: 37728977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study.
    Badawy SM; Abebe KZ; Reichman CA; Checo G; Hamm ME; Stinson J; Lalloo C; Carroll P; Saraf SL; Gordeuk VR; Desai P; Shah N; Liles D; Trimnell C; Jonassaint CR
    JMIR Res Protoc; 2021 May; 10(5):e29014. PubMed ID: 33988517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. App-Delivered Self-Management Intervention Trial selfBACK for People With Low Back Pain: Protocol for Implementation and Process Evaluation.
    Rasmussen CDN; Svendsen MJ; Wood K; Nicholl BI; Mair FS; Sandal LF; Mork PJ; Søgaard K; Bach K; Stochkendahl MJ
    JMIR Res Protoc; 2020 Oct; 9(10):e20308. PubMed ID: 33118959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective Emergency Department Quality Improvement Project to Improve the Treatment of Vaso-Occlusive Crisis in Sickle Cell Disease: Lessons Learned.
    Tanabe P; Freiermuth CE; Cline DM; Silva S
    Jt Comm J Qual Patient Saf; 2017 Mar; 43(3):116-126. PubMed ID: 28334590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: The emergency department providers' perspective.
    Masese RV; Bulgin D; Douglas C; Shah N; Tanabe P
    PLoS One; 2019; 14(5):e0216414. PubMed ID: 31063506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of PARACT (PARAmedical Interventions on Patient ACTivation) on the Cancer Care Pathway: Protocol for Implementation of the Patient Activation Measure-13 Item (PAM-13) Version.
    Verot E; Bouleftour W; Macron C; Rivoirard R; Chauvin F
    JMIR Res Protoc; 2020 Dec; 9(12):e17485. PubMed ID: 33289495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study.
    Badawy SM; DiMartino L; Brambilla D; Klesges L; Baumann A; Burns E; DeMartino T; Jacobs S; Khan H; Nwosu C; Shah N; Hankins JS;
    JMIR Form Res; 2022 Oct; 6(10):e41415. PubMed ID: 36240004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Implementation and Effectiveness of a Mobile Health Intervention to Improve Outcomes for People With HIV in the Washington, DC Cohort: Study Protocol for a Cluster Randomized Controlled Trial.
    Hodges J; Caldwell S; Cohn W; Flickinger T; Waldman AL; Dillingham R; Castel A; Ingersoll K
    JMIR Res Protoc; 2022 Apr; 11(4):e37748. PubMed ID: 35349466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of an Emergency Department Observation Unit-Based Pathway for the Treatment of Uncomplicated Vaso-occlusive Events in Sickle Cell Disease.
    Lyon M; Sturgis L; Lottenberg R; Gibson ME; Eck J; Kutlar A; Gibson RW
    Ann Emerg Med; 2020 Sep; 76(3S):S12-S20. PubMed ID: 32928457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J
    Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.